Scales, C., Greiner, M., Curtis, L., Hammill, B., Peterson, A., Amundsen, C., … Schmader, K. (2016). MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER. Journal of Urology, 195(4S). https://doi.org/10.1016/j.juro.2016.02.793

Scales, Charles, Melissa Greiner, Lesley Curtis, Brad Hammill, Andrew Peterson, Cindy Amundsen, Viviana Martinez-Bianchi, Mitchell Heflin, and Kenneth Schmader. “MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER.” Journal of Urology 195, no. 4S (April 2016). https://doi.org/10.1016/j.juro.2016.02.793.

Scales C, Greiner M, Curtis L, Hammill B, Peterson A, Amundsen C, et al. MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER. Journal of Urology. 2016 Apr;195(4S).

Scales, Charles, et al. “MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER.” Journal of Urology, vol. 195, no. 4S, Ovid Technologies (Wolters Kluwer Health), Apr. 2016. Crossref, doi:10.1016/j.juro.2016.02.793.

Scales C, Greiner M, Curtis L, Hammill B, Peterson A, Amundsen C, Martinez-Bianchi V, Heflin M, Schmader K. MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016 Apr;195(4S).